Uipath Inc (PATH)
NYSE:PATH
Want to see PATH full AI Analyst Report?
Top Page
UiPath
(NYSE:PATH)
Select Model
Select Model
Rating:79Outperform
Price Target:
$12.00
▲(15.27% Upside)
Action:Reiterated
Date:05/29/26
The score is driven primarily by strong financial performance (profitability turnaround, high margins, and robust free cash flow) and a conservatively financed balance sheet. Earnings-call guidance and commentary reinforce improving execution and AI-led enterprise traction, though modest net new ARR and small-customer churn temper the outlook. Technicals are mixed (short-term strength but weaker longer-term trend), and valuation looks reasonable with a mid-range P/E and no dividend support.
Positive Factors
Conservative Balance Sheet
Very low leverage and a conservatively financed balance sheet provide lasting financial flexibility. This supports continued R&D, go-to-market investment, and buybacks through cycles, reducing refinancing risk and enabling strategic optionality as automation demand evolves over months.
Negative Factors
Slowing Revenue/ARR Growth
Top-line growth has slowed versus prior years and net new ARR remains modest relative to base. Slower organic expansion makes sustaining recent margin and profit gains harder, increasing reliance on large deal cycles and execution to drive durable revenue acceleration.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative Balance Sheet
Very low leverage and a conservatively financed balance sheet provide lasting financial flexibility. This supports continued R&D, go-to-market investment, and buybacks through cycles, reducing refinancing risk and enabling strategic optionality as automation demand evolves over months.
Read all positive factors
UiPath Key Performance Indicators (KPIs)
Any
Dollar-Based Net Retention Rate
Tracks how revenue from existing customers changes over time after accounting for expansions, contractions, and churn; a rate above 100% means upsells and cross-sells more than offset losses and indicates healthy land‑and‑expand economics. For UiPath, a high net retention rate suggests sticky automation deployments and predictable growth from the installed base, while a declining rate warns of weakening adoption or pricing pressure.
Tracks how revenue from existing customers changes over time after accounting for expansions, contractions, and churn; a rate above 100% means upsells and cross-sells more than offset losses and indicates healthy land‑and‑expand economics. For UiPath, a high net retention rate suggests sticky automation deployments and predictable growth from the installed base, while a declining rate warns of weakening adoption or pricing pressure.
Data provided by:
The Fly
The FlyUiPath (PATH) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$5.32B
Dividend YieldN/A
Average Volume (3M)44.07M
Price to Earnings (P/E)16.4
Beta (1Y)1.16
Revenue Growth15.24%
EPS GrowthN/A
CountryUS
Employees3,868
SectorTechnology
Sector Strength88
IndustrySoftware - Infrastructure
Share Statistics
EPS (TTM)0.60
Shares Outstanding453,429,570
10 Day Avg. Volume44,853,712
30 Day Avg. Volume44,073,816
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)3.25
Price to Sales (P/S)4.21
P/FCF Ratio19.24
Enterprise Value/Market Cap0.92
Enterprise Value/Revenue2.92
Enterprise Value/Gross Profit3.53
Enterprise Value/Ebitda30.54
Forecast
1Y Price Target
$13.40Price Target Upside28.72% Upside
Rating ConsensusHold
Number of Analyst Covering14
EPS Forecast (FY)0.8
Revenue Forecast (FY)$1.76B
UiPath Business Overview & Revenue Model
Company Description
UiPath Inc. delivers a comprehensive automation ecosystem, specializing in Robotic Process Automation (RPA) solutions, with a significant presence in the United States, Romania, and Japan. The company's integrated software suite empowers organizat...
How the Company Makes Money
UiPath primarily makes money by selling subscriptions to its automation software platform, typically under enterprise agreements that provide customers access to its automation capabilities (e.g., developing, running, and managing automated proces...
UiPath Earnings Call Summary
Earnings Call Date:May 28, 2026
(Q1-2027)
| % Change Since: |
Next Earnings Date:Sep 08, 2026
Earnings Call Sentiment Positive
The call presented strong execution: revenue acceleration, the company’s first GAAP profitable quarter, meaningful non-GAAP margins and free cash flow, healthy cash reserves and active buybacks, and clear momentum in AI and product launches driving large enterprise deals. Key concerns were modest net new ARR relative to the ARR base, churn concentrated in the smallest customers, and expected FX headwinds. Management framed ARR/revenue timing differences as accounting and mix effects and emphasized continued investment in AI, orchestration, and go-to-market execution. Overall, the positive operating and financial progress, coupled with strong AI-driven deal traction and improved profitability, outweigh the highlighted challenges.Positive Updates
Revenue Growth and Strong Quarter
Reported revenue of $418 million, up 17% year-over-year (15% growth when normalizing for a $7 million FX tailwind). Management noted the quarter beat guidance across key financial metrics.
Negative Updates
Modest Net New ARR Relative to Base
Net new ARR was $49 million, which is modest relative to a $1.901 billion ARR base and may signal slower incremental ARR expansion in the near term.
Read all updates
Q1-2027 Updates
Positive
Negative
Revenue Growth and Strong Quarter
Reported revenue of $418 million, up 17% year-over-year (15% growth when normalizing for a $7 million FX tailwind). Management noted the quarter beat guidance across key financial metrics.
Read all positive updates
Company Guidance
UiPath guided Q2 FY27 revenue of $395–$400 million, ARR of $1.929–$1.934 billion, non‑GAAP operating income of approximately $75 million and a basic share count of ~518 million; for full‑year FY27 it expects revenue of $1.776–$1.781 billion, ARR of $2.058–$2.063 billion, non‑GAAP operating income of about $430 million, non‑GAAP adjusted free cash flow of roughly $425 million and non‑GAAP gross margin of ~84%, while noting a nominal incremental FX headwind to ARR and revenue.UiPath Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
88
Very Positive
Cash Flow
84
Very Positive
| Breakdown | TTM | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.67B | 1.61B | 1.43B | 1.31B | 1.06B | 892.25M |
| Gross Profit | 1.39B | 1.34B | 1.18B | 1.11B | 878.53M | 723.38M |
| EBITDA | 160.16M | 117.60M | -60.87M | -53.22M | -298.84M | -496.18M |
| Net Income | 327.41M | 282.33M | -73.69M | -89.88M | -328.35M | -525.59M |
Balance Sheet | ||||||
| Total Assets | 2.90B | 3.18B | 2.87B | 2.95B | 2.74B | 2.57B |
| Cash, Cash Equivalents and Short-Term Investments | 1.31B | 1.47B | 1.63B | 1.88B | 1.76B | 1.87B |
| Total Debt | 83.00M | 81.25M | 77.82M | 67.07M | 63.44M | 51.40M |
| Total Liabilities | 1.00B | 1.10B | 1.02B | 938.64M | 815.05M | 650.53M |
| Stockholders Equity | 1.90B | 2.08B | 1.85B | 2.02B | 1.92B | 1.92B |
Cash Flow | ||||||
| Free Cash Flow | 375.23M | 352.16M | 305.64M | 291.74M | -33.80M | -68.02M |
| Operating Cash Flow | 384.13M | 371.21M | 320.56M | 299.08M | -9.98M | -54.96M |
| Investing Cash Flow | -55.38M | -22.47M | -45.50M | -439.57M | -289.14M | -35.44M |
| Financing Cash Flow | -389.36M | -372.38M | -450.51M | -196.90M | -60.67M | 1.47B |
UiPath Technical Analysis
Negative
10.41
Price Trends
10.69
Negative
11.15
Negative
13.01
Negative
Market Momentum
-0.12
Positive
41.70
Neutral
19.59
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PATH, the sentiment is Negative. The current price of 10.41 is below the 20-day moving average (MA) of 11.13, below the 50-day MA of 10.69, and below the 200-day MA of 13.01, indicating a bearish trend. The MACD of -0.12 indicates Positive momentum. The RSI at 41.70 is Neutral, neither overbought nor oversold. The STOCH value of 19.59 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PATH.
UiPath Risk Analysis
UiPath disclosed 1 risk factors in its most recent earnings report. UiPath reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
UiPath Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $5.32B | 16.42 | 17.29% | ― | 15.24% | ― | |
76 Outperform | $26.76B | -919.15 | -0.99% | ― | 23.64% | 68.36% | |
70 Outperform | $4.48B | 21.80 | 13.99% | ― | 7.06% | -22.01% | |
63 Neutral | $5.15B | -15.88 | -21.49% | ― | 21.38% | 27.92% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | $3.83B | -29.64 | -26.10% | ― | 15.27% | -39.93% |
* Technology Sector Average
PATH
UiPath
10.27
-1.96
-16.03%
ACIW
ACI Worldwide
44.09
-1.28
-2.82%
VRNS
Varonis Systems
33.38
-16.06
-32.48%
MDB
MongoDB
332.75
129.51
63.72%
S
SentinelOne
15.02
-2.48
-14.17%
UiPath Corporate Events
Business Operations and StrategyFinancial DisclosuresRegulatory Filings and Compliance
UiPath Delivers Strong Q1 Results and First GAAP Profit
Positive
May 28, 2026
UiPath reported first quarter fiscal 2027 results on May 28, 2026, with revenue rising 17% year-on-year to $418 million and annualized recurring revenue reaching $1.901 billion, up 12% from a year earlier as of April 30, 2026. The company delivere...
Business Operations and StrategyExecutive/Board Changes
UiPath Elevates Malpani to Chief Product and Technology Officer
Positive
Mar 25, 2026
On March 24, 2026, the UiPath board’s Compensation Committee appointed current Chief Technology Officer Raghavendra (Raghu) Malpani as Chief Product and Technology Officer, effective March 25, 2026, expanding his remit to oversee both produc...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.